PEAK6 Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$8.7M Sell
109,584
-72,740
-40% -$6.04M 0.04% 512
2018
Q1
$16.3M Sell
182,324
-40,781
-18% -$3.91M 0.07% 283
2017
Q4
$23.3M Buy
+223,105
New +$25.2M 0.11% 201
2017
Q1
Sell
-80,263
Closed -$9.61M 5577
2016
Q4
$9.29M Sell
80,263
-17,861
-18% -$1.99M 0.07% 394
2016
Q3
$10.3M Buy
98,124
+40,972
+72% +$4.43M 0.08% 336
2016
Q2
$5.64M Sell
57,152
-30,419
-35% -$3.15M 0.04% 606
2016
Q1
$8.77M Buy
87,571
+23,612
+37% +$2.43M 0.07% 369
2015
Q4
$7.66M Sell
63,959
-93,443
-59% -$10.8M 0.05% 490
2015
Q3
$17M Sell
157,402
-136,210
-46% -$16.9M 0.09% 268
2015
Q2
$34M Buy
293,612
+38,563
+15% +$4.41M 0.2% 69
2015
Q1
$29.4M Buy
255,049
+30,573
+14% +$3.65M 0.22% 56
2014
Q4
$25.1M Buy
224,476
+110,417
+97% +$11.6M 0.19% 90
2014
Q3
$10.8M Buy
114,059
+69,521
+156% +$6.27M 0.08% 287
2014
Q2
$3.83M Sell
44,538
-180,212
-80% -$13.7M 0.04% 676
2014
Q1
$15.7M Buy
224,750
+172,294
+328% +$13.6M 0.13% 134
2013
Q4
$4.43M Buy
+52,456
New +$4.15M 0.03% 815

Other funds holding CELG

PEAK6 Group's CELG Position: Q2 2018 in Review

PEAK6 Group reduced its Celgene Corp (CELG) stake by 40% in Q2 2018, selling an estimated $6.04M and leaving 109,584 shares worth $8.7M. The position accounts for 0.04% of the portfolio, ranked #512.

PEAK6 Group first reported a position in CELG in Q4 2013 and has held it in 16 quarters since. The position peaked at $34M in Q2 2015. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • PEAK6 Group held 109,584 shares of Celgene Corp worth $8.7M as of Q2 2018.
  • PEAK6 Group sold 72,740 Celgene Corp shares in Q2 2018, an estimated $6.04M.
  • Celgene Corp made up 0.04% of PEAK6 Group's portfolio in Q2 2018, its #512 holding.
  • PEAK6 Group first reported a position in Celgene Corp in Q4 2013 and has held it in 16 quarters since.
  • PEAK6 Group's Celgene Corp position peaked at $34M in Q2 2015.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.